News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Tenshi Healthcare Pte. Ltd.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/22/2022 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Disposed of 27,982,529 shares
@ $0 |
|
| 04/22/2022 |
SC 13D/A
| Tenshi Healthcare Pte. Ltd. reports a 25.6% stake in Outlook Therapeutics, Inc. |
| 02/01/2022 |
SC 13D/A
| BioLexis Pte Ltd. reports a 35.7% stake in Outlook Therapeutics, Inc. |
| 12/01/2021 |
SC 13D/A
| BioLexis Pte Ltd. reports a 35.5% stake in Outlook Therapeutics, Inc. |
| 02/02/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/24/2020 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 65.3% stake in Outlook Therapeutics, Inc. |
| 03/23/2020 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Disposed/sold 68,112 convertible preferred
@ $0
Granted 68,112 convertible preferred
@ $0
Exercised 68,112 convertible preferred
@ $0 |
|
| 02/27/2020 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 47.8% stake in Outlook Therapeutics, Inc. |
| 01/31/2020 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 51.6% stake in Outlook Therapeutics, Inc. |
| 01/29/2020 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Disposed/sold 2,093,750 warrants
@ $0
Granted 2,093,750 warrants
@ $0.232, valued at
$485.8k
Disposed/sold 1,282,051 warrants
@ $1, valued at
$1.3M
Granted 1,282,051 warrants
@ $0.232, valued at
$297.4k
Exercised 2,093,750 warrants
@ $0.232, valued at
$485.8k
Exercised 1,282,051 warrants
@ $0.232, valued at
$297.4k
|
|
| 12/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Acquired 1,620 convertible preferred
@ $0 |
|
| 07/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Exercised 2,181,818 shares
@ $0
Exercised 3,636,364 warrants
@ $2.9, valued at
$10.5M
|
|
| 06/19/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 62.4% stake in Outlook Therapeutics, Inc. |
| 04/16/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 70.9% stake in Outlook Therapeutics, Inc. |
| 04/16/2019 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 3,636,364 shares
@ $2.75, valued at
$10M
Granted 3,636,364 warrants
@ $2.9, valued at
$10.5M
|
|
| 04/02/2019 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Acquired 1,542 convertible preferred
@ $0 |
|
| 02/05/2019 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 4,288,624 shares
@ $0.9327, valued at
$4M
|
|
| 02/05/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 80.1% stake in Outlook Therapeutics, Inc. |
| 01/03/2019 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 79.5% stake in Outlook Therapeutics, Inc. |
| 01/03/2019 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 4,288,624 shares
@ $0.9327, valued at
$4M
|
|
| 12/31/2018 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Acquired 1,505 convertible preferred
@ $0 |
|
| 12/31/2018 |
4/A
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Acquired 1,468 convertible preferred
@ $0 |
|
| 12/06/2018 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Outlook Therapeutics, Inc.|
Txns:
| Granted 4,288,624 shares
@ $0.9327, valued at
$4M
|
|
| 11/09/2018 |
4
| BioLexis Pte Ltd. (10% Owner) has filed a Form 4 on Oncobiologics, Inc.|
Txns:
| Granted 8,577,248 shares
@ $0.9327, valued at
$8M
|
|
| 11/09/2018 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 78.1% stake in Oncobiologics, Inc. |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2018 |
4
| GMS Tenshi Holdings Pte. Ltd (10% Owner) has filed a Form 4 on Oncobiologics, Inc.|
Txns:
| Granted 6,526 convertible preferred
@ $0
Disposed/sold 58,735 convertible preferred
@ $0
Granted 58,735 convertible preferred
@ $0 |
|
| 07/20/2018 |
SC 13D/A
| GMS Tenshi Holdings Pte. Ltd reports a 77.7% stake in Oncobiologics, Inc. |
| 06/25/2018 |
4
| GMS Tenshi Holdings Pte. Ltd (10% Owner) has filed a Form 4 on Oncobiologics, Inc.|
Txns:
| Granted 6,377,383 shares
@ $0.975, valued at
$6.2M
Granted 6,377,383 shares
@ $0.975, valued at
$6.2M
Converted 31,572,617 shares
@ $0
Granted 10,256,410 warrants
@ $0.975, valued at
$10M
Granted 10,256,410 warrants
@ $0.975, valued at
$10M
Acquired 4,678 convertible preferred
@ $0
Acquired 6,367 convertible preferred
@ $0
Converted 208,836 convertible preferred
@ $0 |
|
|
|
|